Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 4,828	$ 2,672
Restricted cash		250
Accounts receivable	5,032	4,672
Other current assets	2,294	1,479
Current assets of discontinued operations		3,093
Total current assets	12,154	12,166
Property and equipment, net	480	317
Other intangible assets, net	861	2,132
Operating lease right of use assets	2,439	1,284
Other long-term assets	45	141
Long-term assets of discontinued operations		22,387
Total assets	15,979	38,427
Current liabilities:
Accounts payable	1,050	1,374
Accrued salary and bonus	1,456	2,689
Other accrued expenses	8,419	8,462
Line of credit - current	2,500
Current liabilities of discontinued operations	858	3,157
Total current liabilities	14,283	15,682
Contingent consideration	518	1,383
Operating lease liabilities, net of current portion	1,848	520
Line of credit		1,500
Note payable at fair value	11,165	7,942
Other long-term liabilities	4,701	4,577
Long-term liabilities of discontinued operations		2,705
Total liabilities	32,515	34,309
Commitments and contingencies (Note 11)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding	46,536	46,536
Stockholders’ deficit:
Common stock, $.01 par value; 100,000,000 shares authorized; 4,367,830 and 4,228,169 shares issued, respectively; 4,296,710 and 4,195,412 shares outstanding, respectively	405	403
Additional paid-in capital	187,516	186,106
Accumulated deficit	(249,017)	(227,059)
Treasury stock, at cost (71,120 and 32,757 shares, respectively)	(1,976)	(1,868)
Total stockholders’ deficit	(63,072)	(42,418)
Total liabilities and stockholders’ deficit	(30,557)	(8,109)
Total liabilities, preferred stock and stockholders’ deficit	$ 15,979	$ 38,427